Nurix Therapeutics, Inc. NRIX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s operating lease liabilities (current)?
- Nurix Therapeutics, Inc. (NRIX) reported operating lease liabilities (current) of $3.2M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Nurix Therapeutics, Inc.'s operating lease liabilities (current) decreased by 51.8% year-over-year, from $6.64M to $3.2M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s operating lease liabilities (current) has grown at a -3.3% compound annual growth rate (CAGR), from $3.34M to $2.82M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.